Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Nov 30;21(1):154.
doi: 10.1186/s43141-023-00581-y.

Influenza vaccine: a review on current scenario and future prospects

Dipanshi Gupta  1 , Sumedha Mohan  2
Affiliations
Review

Influenza vaccine: a review on current scenario and future prospects

Dipanshi Gupta et al. J Genet Eng Biotechnol. .

Abstract

Vaccination is a crucial tool in preventing influenza, but it requires annual updates in vaccine composition due to the ever-changing nature of the flu virus. While healthcare and economic burdens have reduced, the virus remains a challenge. Research conducted over the past decade has revealed pathways for improvement through both basic and clinical studies. Viral surveillance plays a vital role in the better selection of candidate viruses for vaccines and the early detection of drug-resistant strains.This page offers a description of future vaccine developments and an overview of current vaccine options. In the coming years, we anticipate significant changes in vaccine production, moving away from traditional egg-based methods towards innovative technologies such as DNA and RNA vaccines. These newer approaches offer significant advantages over traditional egg-based and cell culture-based influenza vaccine manufacturing.

Keywords: Immune response; Influenza vaccine; Recombinant technology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012;30:6461–6471. doi: 10.1016/j.vaccine.2012.07.089. - DOI - PMC - PubMed
    1. Tenforde MW, Kondor RJ, Chung JR, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, Monto AS, Martin ET, Belongia EA, McLean HQ. Effect of antigenic drift on influenza vaccine effectiveness in the United States—2019–2020. Clin Infect Dis. 2021;73(11):e4244–e4250. doi: 10.1093/cid/ciaa1884. - DOI - PMC - PubMed
    1. Asha K, Kumar B. Emerging influenza D virus threat: what we know so far! J Clin Med. 2019;8:192. doi: 10.3390/jcm8020192. - DOI - PMC - PubMed
    1. Dawson WK, Lazniewski M, Plewczynski D. RNA structure interactions and ribonucleoprotein processes of the influenza A virus. Brief Funct Genom. 2017;17:402–414. doi: 10.1093/bfgp/elx028. - DOI - PMC - PubMed
    1. Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. 2020;92(6):548–551. doi: 10.1002/jmv.25722. - DOI - PMC - PubMed

LinkOut - more resources